Salute e Benessere
DOC Pharma: A New Identity for the Generic Drugs Company, Advancing Growth By Targeting Broader Pharmaceutical Market
Since 2017, DOC has undertaken a journey to strengthen its presence in the pharmaceutical market, beginning with expanding its product offerings in multiple therapeutic areas. Since then, the generic drug portfolio has been complemented by the ophthalmic product line, integrated in 2022 through the acquisition of Medivis's portfolio, and the muscle relaxant product line, through the Muscoril® acquisition which has now closed. , an Italian developer of osteoarticular nutraceutical treatments.
said , CEO of DOC Pharma.
Over the years, the Company has remained committed to ensuring access to high-quality drugs at affordable prices. This mission, paired with continuous dialogue and training of healthcare professionals, has made the Company a trusted partner for doctors, pharmacists, and most importantly for patients across all of Italy . Today, the DOC Pharma portfolio includes more than 250 molecules and approximately 700 SKUs covering all main therapeutic areas.
The will expand DOC Pharma's nutraceutical business and treatment offerings, in line with the Company's mission to build a complete product offering of accessible drugs that improve health and patient outcomes. Geopharma's portfolio includes 10 brands supplements based on nutraceutical active ingredients focused on the prevention and treatment of chronic-degenerative conditions.
, CEO of Geopharma
DOC Pharma remains confident in the value of Italian skills and resources. In addition to being founded and headquartered in
Italy , DOC Pharma primarily partners with specialists throughout
Italy in its search for quality across production plants and distribution chains.
DOC Pharma is an Italian pharmaceutical company active in the market of branded and equivalent products. It is the second largest operator in the equivalent medicines segment in Italy . DOC Pharma's portfolio includes over 250 molecules and approximately 700 SKUs covering all main therapeutic areas. DOC Pharma offers a wide range of refundable and non-refundable products distributed in pharmacies across Italy .
For further information, visit the website: https://docpharma.com.
Photo: https://mma.prnewswire.com/media/2618651/DOC_Pharma_Riccardo_Zagaria.jpg
Logo: https://mma.prnewswire.com/media/2618650/DOC_Pharma_Logo.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/doc-pharma-a-new-identity-for-the-generic-drugs-company-advancing-growth-by-targeting-broader-pharmaceutical-market-302374695.html